The Centers for Medicare & Medicaid Services (CMS) released updated guidance for nursing home surveyors that will take effect on February 24, 2025. The updates aim to enhance the quality of care and ensure compliance with evolving standards in long-term care facilities. These revisions, which will be i...
AMDA – The Society for Post-Acute and Long-Term Care Medicine applauds the many recommendations included in yesterday’s National Academies of Sciences, Engineering, and Medicine Report, The National Imperative to Improve Nursing Home Quality: Honoring Our Commitment to Residents, Families and Staff.
...
With the July 2022 Care Compare refresh, the Centers for Medicare & Medicaid Services (CMS) revised the Nursing Home Five Star Quality Rating System to include weekend staffing and staff turnover measures.
The use of anticholinergics, antipsychotics, benzodiazepines, and other potentially harmful medications (PHMs) is associated with particularly poor outcomes in nursing home (NH) residents with Alzheimer's disease and related dementias (ADRD). Our objective was to compare PHM prescribing by NH physicia...
Interventions aimed at managing agitated and aggressive behaviors in dementia without the use of antipsychotics are currently being tested in nursing homes (NHs). Researchers and clinicians require a measure that can capture the severity of residents’ behaviors. We test the internal consistency and constru...
In nursing homes (NHs), psychoactive medication use has received notable attention, but less is known about prescribing in assisted living (AL). This study examined how antipsychotic and antianxiety medication prescribing in AL compares with NHs.
Despite improvements in selected nursing facility (NF) quality measures such as reduction in antipsychotic use; local, state, and national initiatives; and regulatory incentives, the quality of clinical care delivered in this setting remains inconsistent. Herein, recommendations for overcoming barriers to ...
The use of antipsychotics in persons with Parkinson's disease (PD) is common, although their use may aggravate the symptoms of PD. Clozapine and quetiapine are the only antipsychotics recommended in PD treatment guidelines. Information on factors associated with initiation of antipsychotics is needed....